GlobalData on MSN
Novartis and Chai Discovery collaborate on antibody identification
The partnership is an extension of over 12 months of technical engagement between the two companies.
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.
ZURICH, July 6 (Reuters) - Swiss drugmaker Novartis said on Monday it had agreed to pay up to $1.5 billion for U.K.-based ...
Novartis is executing more layoffs at its U.S. headquarters in East Hanover, New Jersey, handing 322 employees pink slips.
Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration with Novartis to advance the discovery of therapeutic antibodies using artificial ...
Hosted on MSN
Novartis axes 550 jobs at Swiss manufacturing site
Novartis has announced plans to lay off 550 staff at its site in Stein, Switzerland, by the end of 2027. This follows the company’s call to shift towards “innovative manufacturing technologies”, which ...
With the latest layoffs, Novartis expects to let go of around 800 employees by the end of 2028. More than half of the cuts ...
Chai Discovery has signed a collaboration with Novartis (NOVN: VX) to use artificial intelligence in the discovery of ...
ADC payload with a differentiated mechanism of action; Combines oncology expertise of Novartis with Myricx Bio’s ...
Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...
Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...
A warehouse fire at an 80-year-old Michigan craft supply company triggered 179 remote worker layoffs in New Jersey — one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results